Search for a command to run...
Indrayani Biotech Ltd. leads the Floriculture sector with strong profitability metrics despite some valuation concerns. While it shows solid revenue growth, its peers exhibit significant weaknesses, particularly in profitability and valuation, suggesting a favorable position for Indrayani Biotech in terms of potential returns.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
Indrayani Biotech Ltd. | ₹11.30 | ₹51.46Cr | 35.59 | 14.40% | 1.71 |
Trescon Ltd. | ₹10.76 | ₹78.00Cr | -266.34 | - | - |
NEHAINT | - | - | 0.00 | - | - |
SIP Industries Ltd. | - | - | 0.00 | - | - |
Valplus Biotech Ltd. | - | - | 0.00 | - | - |
Asian Flora Ltd. | - | - | 0.00 | - | - |
Classic Biotech & Exports Ltd. | - | - | 0.00 | - | - |